Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Immune modulation with tlr9 agonists for cancer treatment 2022-5-01 2022-7-01
TLR9 modulators for treating cancer 2022-2-17 2023-8-31
Tlr9 modulators for treating cancer 2022-2-10 2023-8-10
Treatment of cancer using tlr9 agonist with checkpoint inhibitors 2021-9-14 2022-1-04
Tlr9 modulators for treating cancer 2021-4-18 2021-6-30
Use of a tlr9 agonist in methods for treating covid-19 2021-4-09 2021-10-14
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like … 2020-4-29 2023-3-16 2023-3-16
Inspection apparatus and method 2019-8-27 2019-10-09
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like … 2018-10-12 2020-7-09 2020-7-09
Compositions for inhibiting checkpoint gene expression and uses thereof 2017-10-26 2018-2-15
Toll-like receptor 9 antagonist and methods of use thereof 2017-5-25 2017-9-21
Compositions and methods for inhibiting target rna expression 2017-5-23 2017-11-30
POTENTIATION OF mmRNA THERAPEUTICS 2017-2-01 2017-8-10
Compositions for inhibiting nlrp3 gene expression and uses thereof 2016-11-02 2017-5-11
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like … 2016-8-16 2017-5-25
Compositions for inhibiting dux4 gene expression and uses thereof 2016-7-07 2017-1-12
Novel synthetic agonists of tlr9 tlr9 2016-4-18 2016-11-11
Immunostimulatory oligonucleotide multimers 2015-12-09 2016-5-20
Compositions for inhibiting gene expression and uses thereof 2015-11-11 2016-4-15
COMPOSITION FOR INHIBITION OF GENDER EXPRESSION AND ITS USES 2015-6-10 2017-3-15
Compositions for Inhibiting Gene Expression and Uses Thereof 2014-9-24 2015-2-12
Novel synthetic agonists of TLR9 2014-7-02 2016-5-05 2016-5-05
Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8 2014-5-22 2014-10-16
Modulation of immunostimulatory properties of oligonucleotide-based compounds … 2012-2-24 2012-8-09
Stabilized immune modulatory rna (simra) compounds 2012-1-27 2012-7-19
Immunostimulatory property of oligonucleotide-based compound comprising … 2011-10-17 2012-3-15
Stabilized immunomodulatory oligonucleotides 2011-8-16 2015-2-03 2015-2-03
Novel agonist of TOLL-like receptor 3 and method of use thereof 2011-6-24 2017-2-08 2017-2-08
Synergistic treatment of cancer using immunomers in conjunction with … 2011-1-14 2012-5-03
Synthetic agonists of tlr9 2010-12-03 2011-6-09
Modulation of immunostimulatory properties of oligonucleotide-based compounds … 2010-12-01 2011-9-22
Potent mucosal immune response induced by modified immunomodulatory … 2010-11-23 2011-5-26
Modulation of oligonucleotide cpg-mediated immune stimulation by positional … 2010-11-08 2011-3-10
Oligonucleotide-based compounds as inhibitors of toll-like receptors 2010-7-08 2011-4-28
Potentiation of autoimmune and inflammatory disease treatments by immune … 2010-6-01 2012-7-25
Immunostimulatory properties of oligonucleotide-based compounds comprising … 2010-5-05 2011-12-15
Immunostimulatory activity of palindromic immune modulatory oligonucleotides ( … 2010-5-05 2010-8-26
Synergistic stimulation of the immune system using immunostimulatory … 2010-4-09 2011-6-30
Synthetic RNA-based agonists of TLR7 2010-2-10 2011-8-04
Novel synthetic agonists of tlr9 2010-1-28 2011-12-01
Modulation of immunostimulatory properties by small oligonucleotide-based … 2009-12-03 2010-7-01
Modulation of toll-like receptor 4 expression by antisense oligonucleotides 2009-11-04 2010-5-14
Modulation of toll-like receptor 2 expression by antisense oligonucleotides. 2009-11-04 2011-5-25
Modulation of toll-like receptor 5 expression by antisense oligonucleotides 2009-11-04 2012-3-21
Use of inhibitors of toll-like receptors in the prevention and treatment of … 2009-10-06 2011-6-28
Modulation of myeloid differentation primary response gene 88 (myd88) … 2009-8-07 2011-8-31
Modulation of toll-like receptor 8 expression by antisense oligonucleotides. 2009-8-04 2011-3-04
Regulation of Toll-like receptor 3 expression by antisense oligonucleotides 2009-8-04 2011-12-15
Modulation of toll-like receptor 7 expression by antisense oligonucleotides 2009-8-03 2011-4-15
MODULATION OF OLIGONUCLEOTIDE CpG INDUCIBLE IMMUNOSTIMULATION BY POSITIONAL … 2009-8-03 2009-12-17
Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides 2009-7-28 2011-8-24
Immunostimulatory properties of oligonucleotide-based compounds comprising … 2008-10-21 2010-6-10
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like … 2008-10-02 2013-3-19 2013-3-19
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like … 2008-10-02 2010-4-08
Toll like receptor modulators. 2008-8-15 2010-3-10
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like … 2008-6-17 2009-4-02
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like … 2008-6-17 2009-12-23
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like … 2008-6-17 2009-12-23
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like … 2008-6-17 2009-3-26
Short immunomodulatory oligonucleotides 2007-10-24 2010-12-14 2010-12-14
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like … 2007-5-03 2013-2-19 2013-2-19
Novel synthetic agonists of TOll-like receptors containing CG dinucleotide … 2006-12-19 2009-3-04
Novel synthetic agonists of toll-like receptors containing CG dinucleotide … 2006-12-19 2008-11-13
Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide … 2006-12-12 2008-1-31
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide … 2006-8-09 2008-5-15 2008-5-15
Modulation of oligonucleotide CpG-mediated immune stimulation by positional … 2006-2-24 2006-3-23
Synergistic inhibition of vegf and modulation of the immune response 2005-11-08 2006-11-30
Immunostimulatory properties of oligonucleotide-based compounds comprising … 2005-11-07 2007-5-18
Immunostimulatory properties of oligonucleotide-based compounds comprising … 2005-11-07 2013-7-31 2013-7-31
Comprise the immunostimulatory properties of the compound based on … 2005-11-07 2015-11-18 2015-11-18